483
Daniel Norman, M.D.FDA 483 - Daniel Norman, M.D. - September 02, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Daniel Norman, M.D. in Santa Monica, CA, a clinical investigator, revealed a significant deviation from an investigational plan. The firm failed to conduct an investigation in accordance with the signed statement of investigator and protocol. Specifically, subjects were enrolled in a study while on prohibited concomitant medications, indicating a lack of adherence to study procedures.
Open in Dashboard
ID · d8d47ff9-b1a2-43f1-aa99-b9a2650b1975